Article Details

Is big pharma backtracking from neurosciences? - BioSpectrum Asia

Retrieved on: 2021-06-16 10:07:30

Tags for this article:

Click the tags to see associated articles and topics

Is big pharma backtracking from neurosciences? - BioSpectrum Asia. View article details on hiswai:

Excerpt

The majority of the big pharma firms have retreated from neurosciences ... In 2019, Amgen ended its neuroscience research and early development ...

Article found on: www.biospectrumasia.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up